Global CAR-T Cellular Immunotherapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 75
Published Date: 09 Jul 2021
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The CAR-T Cellular Immunotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global CAR-T Cellular Immunotherapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global CAR-T Cellular Immunotherapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
CAR-T Cellular Immunotherapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Allogeneic
Autologous
Market segment by Application, can be divided into
Hospital
Pharmacy
Other
Market segment by players, this report covers
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe CAR-T Cellular Immunotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of CAR-T Cellular Immunotherapy, with revenue, gross margin and global market share of CAR-T Cellular Immunotherapy from 2019 to 2021.
Chapter 3, the CAR-T Cellular Immunotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and CAR-T Cellular Immunotherapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe CAR-T Cellular Immunotherapy research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of CAR-T Cellular Immunotherapy
1.2 Classification of CAR-T Cellular Immunotherapy by Type
1.2.1 Overview: Global CAR-T Cellular Immunotherapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global CAR-T Cellular Immunotherapy Revenue Market Share by Type in 2020
1.2.3 Allogeneic
1.2.4 Autologous
1.3 Global CAR-T Cellular Immunotherapy Market by Application
1.3.1 Overview: Global CAR-T Cellular Immunotherapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global CAR-T Cellular Immunotherapy Market Size & Forecast
1.5 Global CAR-T Cellular Immunotherapy Market Size and Forecast by Region
1.5.1 Global CAR-T Cellular Immunotherapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global CAR-T Cellular Immunotherapy Market Size by Region, (2016-2021)
1.5.3 North America CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.4 Europe CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.6 South America CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa CAR-T Cellular Immunotherapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 CAR-T Cellular Immunotherapy Market Drivers
1.6.2 CAR-T Cellular Immunotherapy Market Restraints
1.6.3 CAR-T Cellular Immunotherapy Trends Analysis
2.1 Fosun Kite Biotechnology
2.1.1 Fosun Kite Biotechnology Details
2.1.2 Fosun Kite Biotechnology Major Business
2.1.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product and Solutions
2.1.4 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Fosun Kite Biotechnology Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Product and Solutions
2.2.4 Gilead Sciences CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis CAR-T Cellular Immunotherapy Product and Solutions
2.3.4 Novartis CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product and Solutions
2.4.4 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
3.1 Global CAR-T Cellular Immunotherapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 CAR-T Cellular Immunotherapy Players Market Share
3.2.2 Top 10 CAR-T Cellular Immunotherapy Players Market Share
3.2.3 Market Competition Trend
3.3 CAR-T Cellular Immunotherapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global CAR-T Cellular Immunotherapy Revenue and Market Share by Type (2016-2021)
4.2 Global CAR-T Cellular Immunotherapy Market Forecast by Type (2021-2026)
5.1 Global CAR-T Cellular Immunotherapy Revenue Market Share by Application (2016-2021)
5.2 CAR-T Cellular Immunotherapy Market Forecast by Application (2021-2026)
6.1 North America CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
6.2 North America CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
6.3 North America CAR-T Cellular Immunotherapy Market Size by Country
6.3.1 North America CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
6.3.2 United States CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
6.3.3 Canada CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
6.3.4 Mexico CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.1 Europe CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
7.2 Europe CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
7.3 Europe CAR-T Cellular Immunotherapy Market Size by Country
7.3.1 Europe CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
7.3.2 Germany CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.3 France CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.5 Russia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
7.3.6 Italy CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.1 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
8.2 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
8.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size by Region
8.3.1 Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2016-2026)
8.3.2 China CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.3 Japan CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.4 South Korea CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.5 India CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
8.3.7 Australia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
9.1 South America CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
9.2 South America CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
9.3 South America CAR-T Cellular Immunotherapy Market Size by Country
9.3.1 South America CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
9.3.2 Brazil CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
9.3.3 Argentina CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10.1 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2016-2026)
10.2 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2016-2026)
10.3 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country
10.3.1 Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2016-2026)
10.3.2 Turkey CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
10.3.4 UAE CAR-T Cellular Immunotherapy Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global CAR-T Cellular Immunotherapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global CAR-T Cellular Immunotherapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market CAR-T Cellular Immunotherapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region (2021-2026)
Table 6. Fosun Kite Biotechnology Corporate Information, Head Office, and Major Competitors
Table 7. Fosun Kite Biotechnology Major Business
Table 8. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product and Solutions
Table 9. Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR-T Cellular Immunotherapy Product and Solutions
Table 13. Gilead Sciences CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis CAR-T Cellular Immunotherapy Product and Solutions
Table 17. Novartis CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product and Solutions
Table 21. Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Players (2019-2021)
Table 23. Global CAR-T Cellular Immunotherapy Revenue Share by Players (2019-2021)
Table 24. Breakdown of CAR-T Cellular Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. CAR-T Cellular Immunotherapy Players Head Office, Products and Services Provided
Table 26. CAR-T Cellular Immunotherapy Mergers & Acquisitions in the Past Five Years
Table 27. CAR-T Cellular Immunotherapy New Entrants and Expansion Plans
Table 28. Global CAR-T Cellular Immunotherapy Revenue (USD Million) by Type (2016-2021)
Table 29. Global CAR-T Cellular Immunotherapy Revenue Share by Type (2016-2021)
Table 30. Global CAR-T Cellular Immunotherapy Revenue Forecast by Type (2021-2026)
Table 31. Global CAR-T Cellular Immunotherapy Revenue by Application (2016-2021)
Table 32. Global CAR-T Cellular Immunotherapy Revenue Forecast by Application (2021-2026)
Table 33. North America CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 34. North America CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 35. North America CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 36. North America CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 37. North America CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 38. North America CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific CAR-T Cellular Immunotherapy Revenue by Region (2021-2026) & (USD Million)
Table 51. South America CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 52. South America CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 53. South America CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 54. South America CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 55. South America CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 56. South America CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa CAR-T Cellular Immunotherapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. CAR-T Cellular Immunotherapy Picture
Figure 2. Global CAR-T Cellular Immunotherapy Revenue Market Share by Type in 2020
Figure 3. Allogeneic
Figure 4. Autologous
Figure 5. CAR-T Cellular Immunotherapy Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Other Picture
Figure 9. Global CAR-T Cellular Immunotherapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global CAR-T Cellular Immunotherapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region (2016-2026)
Figure 12. Global CAR-T Cellular Immunotherapy Revenue Market Share by Region in 2020
Figure 13. North America CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa CAR-T Cellular Immunotherapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. CAR-T Cellular Immunotherapy Market Drivers
Figure 19. CAR-T Cellular Immunotherapy Market Restraints
Figure 20. CAR-T Cellular Immunotherapy Market Trends
Figure 21. Fosun Kite Biotechnology Recent Developments and Future Plans
Figure 22. Gilead Sciences Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 25. Global CAR-T Cellular Immunotherapy Revenue Share by Players in 2020
Figure 26. CAR-T Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players CAR-T Cellular Immunotherapy Revenue Market Share in 2020
Figure 28. Global Top 10 Players CAR-T Cellular Immunotherapy Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global CAR-T Cellular Immunotherapy Revenue Share by Type in 2020
Figure 31. Global CAR-T Cellular Immunotherapy Market Share Forecast by Type (2021-2026)
Figure 32. Global CAR-T Cellular Immunotherapy Revenue Share by Application in 2020
Figure 33. Global CAR-T Cellular Immunotherapy Market Share Forecast by Application (2021-2026)
Figure 34. North America CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 35. North America CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 36. North America CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 37. United States CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 41. Europe CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 42. Europe CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 43. Germany CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific CAR-T Cellular Immunotherapy Revenue Market Share by Region (2016-2026)
Figure 51. China CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 58. South America CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 59. South America CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 60. Brazil CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa CAR-T Cellular Immunotherapy Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa CAR-T Cellular Immunotherapy Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa CAR-T Cellular Immunotherapy Revenue Market Share by Country (2016-2026)
Figure 65. Turkey CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE CAR-T Cellular Immunotherapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Fosun Kite Biotechnology Gilead Sciences Novartis Bristol-Myers Squibb
18 Jan 2022
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
